These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 1306563)
1. Cytokines and monoclonal antibodies: an introduction of their current and future applications to cancer and other diseases. Borden E Med Sect Proc; 1992; ():51-62. PubMed ID: 1306563 [No Abstract] [Full Text] [Related]
2. Monoclonal antibodies, cytokines and fusion proteins in the treatment of malignant disease. Hank JA; Albertini MR; Sondel PM Cancer Chemother Biol Response Modif; 1999; 18():210-22. PubMed ID: 10800484 [No Abstract] [Full Text] [Related]
3. [Antitumor immunotherapy]. Błoński JZ; Warzocha K Postepy Hig Med Dosw; 1994; 48(6):701-28. PubMed ID: 7675731 [TBL] [Abstract][Full Text] [Related]
5. [Present status of studies on the application of immunology to the diagnosis and therapy of cancer, with emphasis on monoclonal antibodies and cytokines]. Tokunaga T Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1358-66. PubMed ID: 3296954 [TBL] [Abstract][Full Text] [Related]
6. Immunotherapy: the last 25 years. Plunkett TA; Miles DW Cancer Treat Rev; 1999 Dec; 25(6):355-63. PubMed ID: 10644501 [No Abstract] [Full Text] [Related]
8. [Anemia and immunotherapy]. Dorval T Bull Cancer; 2003 Apr; 90 Spec No():S158-60. PubMed ID: 12856428 [TBL] [Abstract][Full Text] [Related]
9. Cancer immunotherapy. Schuster M; Nechansky A; Kircheis R Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244 [TBL] [Abstract][Full Text] [Related]
10. Prostate cancer vaccines: current status. Hwang LC; Fein S; Levitsky H; Nelson WG Semin Oncol; 1999 Apr; 26(2):192-201. PubMed ID: 10597730 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies: the possibilities for cancer therapy. Poynton CH; Reading CL Exp Biol; 1984; 43(1):13-33. PubMed ID: 6398221 [TBL] [Abstract][Full Text] [Related]
12. European Organization for Research and Treatment of Cancer Workshop. Problems and prospects in current therapeutic application of molecular biology. McVie JG; Muggia FM Cancer Res; 1987 Jun; 47(11):3032. PubMed ID: 3567917 [No Abstract] [Full Text] [Related]
13. Specific targeting of cancer with monoclonal antibodies: diagnostic and therapeutic applications. Abrams PG; Morgan AC; Fritzberg R Cancer Invest; 1990; 8(2):287-8. PubMed ID: 2400950 [No Abstract] [Full Text] [Related]
14. Strategies for the development of more effective adjuvant therapy of melanoma: current and future explorations of antibodies, cytokines, vaccines, and combinations. Kirkwood JM; Moschos S; Wang W Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2331s-2336s. PubMed ID: 16609054 [TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody therapy of cancer. Jurcic JG; Scheinberg DA; Houghton AN Cancer Chemother Biol Response Modif; 1993; 14():129-49. PubMed ID: 8312102 [No Abstract] [Full Text] [Related]
17. The present and future role of monoclonal antibodies in the management of cancer. Front Radiat Ther Oncol; 1990; 24():1-269. PubMed ID: 2341046 [No Abstract] [Full Text] [Related]
18. Targeted therapies in solid tumors: monoclonal antibodies and small molecules. Weiner LM; Borghaei H Hum Antibodies; 2006; 15(3):103-11. PubMed ID: 17065741 [TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of metastasis. Dallal RM; Lotze MT Surg Oncol Clin N Am; 2001 Apr; 10(2):433-47, xi. PubMed ID: 11382596 [TBL] [Abstract][Full Text] [Related]